CB1-IN-3
CB1-IN-3 (Compound 6i) is a potent cannabinoid type 1 receptor (CB1) inhibitor. CB1-IN-3 is promising for research of obesity, inflammation, and neurological diseases[1].
Product Specifications
UNSPSC
12352005
Target
Cannabinoid Receptor
Related Pathways
GPCR/G Protein; Neuronal Signaling
Field of Research
Metabolic Disease; Inflammation/Immunology; Neurological Disease
Smiles
O=C(NC1=CC=CC(C(CN2C=CC=N2)=O)=C1)NC3=CC=C(C)C([N+]([O-])=O)=C3
Molecular Formula
C19H17N5O4
Molecular Weight
379.37
References & Citations
[1]Tsemperlidou E, et al. Synthesis of New N, N'-Diarylureas and Their Theoretical Study as Cannabinoid-1 Receptor Inhibitors. Chempluschem. 2025 Jun 13:e2500270.
Shipping Conditions
Room temperature
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-174838/
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CB1
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
bsm-33105M-PerCP 100 µL
Histone H3 (mono methyl K79) Monoclonal Antibody, PerCP Conjugated
Ask
View Details 